The size of the North American Surgical Sutures Market is forecasted to be growing at a CAGR of 4.7%. The market is predicted to grow USD 1.74 billion by 2028 from USD 1.38 billion in 2023.
Surgical sutures are the medical devices used to make stitches and close the internal parts that are opened during surgery.
Increasing implementations of surgical sutures owing to CE and FDA marking approvals at escalated rates, advancements in technology, and growing requirement to control blood loss in patients, the ability of sutures to heal the dysfunctional tissues faster are majorly driving the North American surgical sutures market. In addition, the ability of absorbable sutures to be ingested in the body is expanding its demand in the market and is likely to offer growth opportunities in the forecast period. New and innovative surgical sutures and techniques are emerging in the market due to governments' welcoming regulations and policies.
With the increasing investments due to growing demand, the key market players are keen to expand the product portfolios by investing in R & D to develop advanced and efficient surgical sutures, and by merging with other companies are further expanding the market growth.
The factors restricting the growth of the North American surgical sutures market are wound closure devices that are emerging as alternatives to surgical sutures and increasing the adoption rate of minimally invasive surgeries in developing countries. In addition, the cost associated with the surgical sutures market is expensive, which is not affordable, which is one major factor restraining market growth.
This research report on the North American surgical sutures market has been segmented and sub-segmented into the following categories:
By End User:
Regionally, in 2022, the North American market contributed the largest share to the global surgical sutures market and is likely to be dominant during the forecast period. The growth is attributed to the continually increasing number of cardiovascular surgeries in Canada and the U.S. The emergence of multifilament and braided surgical sutures into the market developed by the manufacturers in the United States. In addition, increasing incidences of chronic diseases, favorable steps by the government in launching reimbursement policies, developed healthcare infrastructure, and growing elder people population are major factors driving the market's demand.
The United States Surgical Sutures Market is estimated to account for the majority of the shares in the North American market. The booming economy is propelling the growth rate of the market in this region. In addition, an increasing number of surgeries, particularly related to cardiac, is enhancing the market's demand. Following the U.S., the Canadian surgical sutures market is ruling with dominant shares of the market. The existence of two or more filaments knitted surgical sutures manufactured and delivered into the market is driving the market of surgical sutures.
KEY MARKET PLAYERS:
Companies playing a leading role in the North American Surgical Sutures Market profiled in this report are Johnson & Johnson Inc., B. Braun Melsungen AG, Smith & Nephew PLC, Demetech Corporation, Conmed Corporation, W.L. Gore & Associates, Boston Scientific Corporation, 3M Healthcare, Medtronic Inc., and Sutures India Pvt Ltd.
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]